Global Health Future Growth
Future criteria checks 4/6
Global Health is forecast to grow earnings and revenue by 20.2% and 14.6% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 17.4% in 3 years.
Key information
20.2%
Earnings growth rate
19.5%
EPS growth rate
| Healthcare earnings growth | 27.3% |
| Revenue growth rate | 14.6% |
| Future return on equity | 17.4% |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
The Return Trends At Global Health (NSE:MEDANTA) Look Promising
Sep 01
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case
Aug 02We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease
Jul 15Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion
May 22Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 22Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)
May 04Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?
Apr 12Is Global Health (NSE:MEDANTA) A Risky Investment?
Mar 22Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher
Feb 13There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital
Jan 18With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case
Dec 26Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jun 01Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors
Mar 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 49,391 | 7,857 | 5,833 | 10,077 | 11 |
| 3/31/2026 | 43,208 | 6,450 | 3,812 | 8,728 | 12 |
| 3/31/2025 | 36,996 | 5,116 | 2,004 | 7,065 | 12 |
| 9/30/2024 | 34,627 | 4,882 | 1,915 | 6,288 | N/A |
| 6/30/2024 | 33,566 | 4,825 | N/A | N/A | N/A |
| 3/31/2024 | 32,751 | 4,782 | 3,335 | 6,121 | N/A |
| 12/31/2023 | 31,660 | 4,519 | N/A | N/A | N/A |
| 9/30/2023 | 30,277 | 4,089 | 4,024 | 6,400 | N/A |
| 6/30/2023 | 28,498 | 3,694 | N/A | N/A | N/A |
| 3/31/2023 | 27,099 | 3,261 | 4,085 | 6,445 | N/A |
| 12/31/2022 | 25,164 | 2,426 | N/A | N/A | N/A |
| 6/30/2022 | 23,043 | 2,132 | 1,109 | 3,724 | N/A |
| 3/31/2022 | 21,725 | 1,962 | 368 | 3,113 | N/A |
| 3/31/2021 | 14,519 | 288 | 960 | 2,418 | N/A |
| 3/31/2020 | 15,182 | 363 | -132 | 1,751 | N/A |
| 3/31/2019 | 14,782 | 610 | -1,496 | 1,501 | N/A |
| 3/31/2018 | 13,677 | 329 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDANTA's forecast earnings growth (20.2% per year) is above the savings rate (6.7%).
Earnings vs Market: MEDANTA's earnings (20.2% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: MEDANTA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MEDANTA's revenue (14.6% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: MEDANTA's revenue (14.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDANTA's Return on Equity is forecast to be low in 3 years time (17.4%).